unknown
Stage
2
Investors
About
PhiTech develops a multi-omics AI platform that integrates genomic and transcriptomic data to accelerate and improve diagnostic accuracy for rare diseases and hereditary cancers.
Explore PhiTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.